Mativ Q3 adjusted profit beat estimates driven by price management

Mativ Holdings

05/11/2025 21:43

Overview

Mativ Q3 sales rise 3% yr/yr, beating analyst expectations

Adjusted EPS for Q3 beats consensus, reflecting strong operational performance

Adjusted EBITDA for Q3 beats analyst estimates, highest margin since 2022 merger

Outlook

Company did not provide specific guidance for future quarters or full year in the statement

Result Drivers

ORGANIC VOLUME INCREASES - Co attributes strong Q3 performance to higher organic volume across both segments

PRICE MANAGEMENT - Co cites disciplined price versus input cost management as key factor in achieving highest adjusted EBITDA margin since merger

SEGMENT SALES GROWTH - Filtration & Advanced Materials segment sales grew due to higher volume/mix and favorable currency translation, despite lower selling prices

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
Beat
$513.70 mln
$505 mln (1 Analyst)
Q3 Adjusted EPS
Beat
$0.39
$0.27 (1 Analyst)
Q3 EPS
-$0.06
Q3 Adjusted EBITDA
Beat
$66.80 mln
$65 mln (1 Analyst)

Analyst Coverage

The one available analyst rating on the shares is "strong buy"

The average consensus recommendation for the commodity chemicals peer group is "buy."

Wall Street's median 12-month price target for Mativ Holdings Inc is $15.50, about 33.7% above its November 4 closing price of $10.28

The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release: ID:nBwpjTWFa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)